Inflection Biosciences
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$814K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of small molecule therapeutics intended to help in the treatment of cancer. The company's small molecule therapeutics suggest potential application in a range of treatment for solid tumours and haematological malignancies, enabling health care providers to treat their patients in an enhanced way.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- Suite 15, Anglesea House
- Carysfort Avenue, Blackrock County
- Dublin
- Ireland
+353 (01) 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Inflection Biosciences’s full profile, request a free trial.
Inflection Biosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 09-Mar-2015 | $814K | 00.000 | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 04-Jun-2013 | 00000 | 00000 | Completed | Startup |
Inflection Biosciences Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyteir Therapeutics | Venture Capital-Backed | Cambridge, MA | 0 | 0000 | 00000000000 | 0000 |
| 0000000 0000000000 | Venture Capital-Backed | Diepenbeek, Belgium | 0 | 000.00 | 00000000000 | 000.00 |
| 0000 0000000000 | Venture Capital-Backed | Beijing, China | 0000 | 0000000000 0 | 0000 | |
| 00000000 000000000 | Private Equity-Backed | San Francisco, CA | 0000 | 0000000 0000 | 0000 | |
| 00000000 | Formerly VC-backed | Florham Park, NJ | 0 | 00000000 |
Inflection Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Michael Smurfit | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Enterprise Ireland | Government | Minority | 000 0000 | 000000 0 |
Inflection Biosciences Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Darren Cunningham | Chief Executive Officer, Board Member & Co-Founder | ||
| Michael O'Neill Ph.D | Director, Research & Development, Board Member & Co-Founder |
Inflection Biosciences Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Conor Mallaghan | Self | Board Member | 000 0000 | |
| Darren Cunningham | Inflection Biosciences | Chief Executive Officer, Board Member & Co-Founder | 000 0000 | |
| John Lynch | Inflection Biosciences | Board Member | 000 0000 | |
| John Scanlan Ph.D | Inflection Biosciences | Co-Founder & Board Member | 000 0000 | |
| Michael O'Neill Ph.D | Inflection Biosciences | Director, Research & Development, Board Member & Co-Founder | 000 0000 |